Adrian G Zucco
Overview
Explore the profile of Adrian G Zucco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rasmussen K, Dos Santos Q, Macpherson C, Zucco A, Gjaerde L, Ilett E, et al.
Metabolites
. 2023 Sep;
13(9).
PMID: 37755248
Immune dysfunction resulting from allogeneic haematopoietic stem cell transplantation (aHSCT) predisposes one to an elevated risk of cytomegalovirus (CMV) infection. Changes in metabolism have been associated with adverse outcomes, and...
2.
Zucco A, Bennedbaek M, Ekenberg C, Gabrielaite M, Leung P, Polizzotto M, et al.
AIDS
. 2023 Aug;
37(11):1643-1650.
PMID: 37534724
Objective: Human leucocyte antigen (HLA) class I alleles are the main host genetic factors involved in controlling HIV-1 viral load (VL). Nevertheless, HLA diversity has proven a significant challenge in...
3.
Murray D, Grund B, MacPherson C, Ekenberg C, Zucco A, Reekie J, et al.
AIDS
. 2022 Dec;
37(3):379-387.
PMID: 36473831
Introduction: Identifying genetic factors that influence HIV-pathogenesis is critical for understanding disease pathways. Previous studies have suggested a role for the human gene ten-eleven methylcytosine dioxygenase 2 (TET2) in modulating...
4.
Jensen C, Costa J, Norgaard J, Zucco A, Neesgaard B, Niemann C, et al.
Sci Rep
. 2022 Dec;
12(1):21019.
PMID: 36471093
Spatial resolution in existing chest x-ray (CXR)-based scoring systems for coronavirus disease 2019 (COVID-19) pneumonia is low, and should be increased for better representation of anatomy, and severity of lung...
5.
Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning
Zucco A, Agius R, Svanberg R, Moestrup K, Marandi R, Macpherson C, et al.
Sci Rep
. 2022 Aug;
12(1):13879.
PMID: 35974050
Interpretable risk assessment of SARS-CoV-2 positive patients can aid clinicians to implement precision medicine. Here we trained a machine learning model to predict mortality within 12 weeks of a first...
6.
Moestrup K, Reekie J, Zucco A, Jensen T, Jensen J, Wiese L, et al.
Clin Infect Dis
. 2022 Aug;
76(3):e82-e89.
PMID: 35938291
Background: Many interventional in-patient coronavirus disease 2019 (COVID-19) trials assess primary outcomes through day 28 post-randomization. Since a proportion of patients experience protracted disease or relapse, such follow-up period may...
7.
Gabrielaite M, Bennedbaek M, Zucco A, Ekenberg C, Murray D, Kan V, et al.
J Infect Dis
. 2021 May;
224(12):2053-2063.
PMID: 33974707
Background: Understanding the genetic interplay between human hosts and infectious pathogens is crucial for how we interpret virulence factors. Here, we tested for associations between HIV and host genetics, and...
8.
Ekenberg C, Reekie J, Zucco A, Murray D, Sharma S, MacPherson C, et al.
AIDS
. 2021 Feb;
35(5):783-789.
PMID: 33587436
Objectives: The Strategic Timing of AntiRetroviral Treatment (START) and Strategies for Management of Antiretroviral Therapy (SMART) trials demonstrated that ART can partly reverse clinically defined immune dysfunction induced by HIV...
9.
Ekenberg C, Tang M, Zucco A, Murray D, Macpherson C, Hu X, et al.
J Infect Dis
. 2019 Jun;
220(8):1325-1334.
PMID: 31219150
The impact of variation in host genetics on replication of human immunodeficiency virus type 1 (HIV-1) in demographically diverse populations remains uncertain. In the current study, we performed a genome-wide...